G
Giacomo Dell'Antonio
Researcher at Vita-Salute San Raffaele University
Publications - 55
Citations - 3084
Giacomo Dell'Antonio is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 20, co-authored 53 publications receiving 2746 citations. Previous affiliations of Giacomo Dell'Antonio include University of Milan.
Papers
More filters
Journal ArticleDOI
Pancreatic cancers require autophagy for tumor growth
Shenghong Yang,Xiaoxu Wang,Gianmarco Contino,Marc Liesa,Ergun Sahin,Haoqiang Ying,Alexandra S. Bause,Ying-Hua Li,Jayne M. Stommel,Giacomo Dell'Antonio,Josef Mautner,Giovanni Tonon,Marcia C. Haigis,Orian S. Shirihai,Claudio Doglioni,Nabeel Bardeesy,Alec C. Kimmelman +16 more
TL;DR: Inhibition of autophagy by genetic means or chloroquine treatment leads to robust tumor regression and prolonged survival in pancreatic cancer xenografts and genetic mouse models, and drugs that inactivate this process may have a unique clinical utility in treating pancreatic cancers and other malignancies with a similar dependence on Autophagy.
Journal ArticleDOI
Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression
Matteo Trudu,Sylvie Janas,Chiara Lanzani,Huguette Debaix,Huguette Debaix,Céline Schaeffer,Masami Ikehata,Lorena Citterio,Sylvie Demaretz,Francesco Trevisani,Giuseppe Ristagno,Bob Glaudemans,Kamel Laghmani,Giacomo Dell'Antonio,Johannes Loffing,Maria Pia Rastaldi,Paolo Manunta,Olivier Devuyst,Olivier Devuyst,Luca Rampoldi +19 more
TL;DR: The findings point to uromodulin as a therapeutic target for lowering blood pressure and preserving renal function and the relevance of this mechanism in humans is demonstrated by showing that pharmacological inhibition of NKCC2 was more effective in lowering blood pressured patients who are homozygous for UMOD promoter risk variants than in other hypertensive patients.
Journal ArticleDOI
PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation.
Fausto Fazzini,Giuseppe Peri,Andrea Doni,Giacomo Dell'Antonio,Elena Dal Cin,Enrica Bozzolo,Francesca D'Auria,Luisa Praderio,Gianfranco Ciboddo,Maria Grazia Sabbadini,Angelo A. Manfredi,Alberto Mantovani,Patrizia Rovere Querini +12 more
TL;DR: PTX3 represents a novel acute-phase reactant produced at sites of active vasculitis, and did not correlate with CRP levels in Vasculitis patients.
Journal ArticleDOI
Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP.
TL;DR: Intraplantar administration of oATP into inflamed paws significantly relieved inflammatory pain and the antinociceptive effect of o ATP was independent of the immune-cell recruitment.
Journal ArticleDOI
Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia.
Patrizia Rovere-Querini,Simona Antonacci,Giacomo Dell'Antonio,Anna Angeli,Giada Almirante,Elena Dal Cin,Luca Valsecchi,Chiara Lanzani,Maria Grazia Sabbadini,Claudio Doglioni,Angelo A. Manfredi,Maria Teresa Castiglioni +11 more
TL;DR: Defects in the homeostatic response to cell death/remodeling events, revealed by enhanced levels of PTX3, could be implicated in preeclampsia.